| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_783b576d61b30f4f7a3371f64f5462ac |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0512 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3604
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-367
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3826
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-383
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-0036
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3873 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-04 |
| filingDate |
2006-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d9288ecf40b055a4bc653a4684e5f1e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fdea465bce9cf223a16bbcb668c0751
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4a159a792bfce0bb7c08f8576e86ca1 |
| publicationDate |
2010-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2010010290-A1 |
| titleOfInvention |
Smooth muscle implant for managing a medical condition |
| abstract |
The present invention relates to an implant for managing a medical condition. In particular, it relates to medical treatments which employ smooth muscle implant and discloses a method of augmenting a smooth muscle implant for management of a human medical condition. Augmentation may be by a number of methods. It may be by utilising neurotrophic or trophic factors to assist growth of the smooth muscle tissue or nerve growth within the smooth muscle tissue, or revascularisation of the smooth muscle tissue. It may be by utilising tissue engineering to grow smooth muscle tissue. It may be by adding proliferative smooth muscle cells and/or smooth muscle stem cells for the smooth muscle. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11400299-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11383063-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10688278-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020238961-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015005850-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11311367-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11197992-B2 |
| priorityDate |
2005-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |